Debargha Basuli, MD PhD (@DebarghaBasuli) profile picture

Nephrology Asst Professor @ECUHealth_IM I Transplant Nephrology @OHSUNephrology I

Joined November 2021
Photo by Debargha Basuli, MD PhD (@DebarghaBasuli)
Debargha Basuli, MD PhD retweeted
SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art doi.org/10.1093/ckj/sfaf350
59
135
5,042
Debargha Basuli, MD PhD retweeted
Comparison of Kidney Assessment Tools : Traditional and Emerging. #KDIGO AKI Guidelines 2026 #KIReport
12
58
2,506
Debargha Basuli, MD PhD retweeted
Confession: I LOVE hyponatremia 🤓 (I know, I know. What can I say, I'm a true internist!) HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary! Here are my top 10 hyponatremia tips and tricks - a 🧵
35
518
26
2,752
327,276
Debargha Basuli, MD PhD retweeted
Fluid overload occurs frequently in critically ill patients with AKI and is one of the indications for continuous kidney replacement therapy (CKRT). In this article, the authors state that available and emerging tools help predict and monitor volume status more actively and dynamically to best design UF strategies that avoid hypotension but alleviate congestion. bit.ly/CJASN0650 @GonzaRGuerrero
2
54
4
140
11,853
Debargha Basuli, MD PhD retweeted
KIDNEYcon Registration is Open! April 6-8, 2024 Little Rock, AR kidneycon.org/registration Little Rock will experience the 2024 Total Solar Eclipse Discount room rates at the DoubleTree Hotel! @NephroRock @nephrosharma @nephrosingh @VelezNephHepato @kidney_boy
2
16
6
33
20,803
Debargha Basuli, MD PhD retweeted
Re-reading excellent thread by @NephroMD. In Winzeler paper, UOsm>=500 is highly specific for non-responsiveness but v. insensitive 🤔How about: UOsm>500: don't bother with FR UOsm<300: FR should be first-line approach 300-500: Consider trial of FR ❓
This Post is from an account that no longer exists. Learn more
5
1
20
2,511
Debargha Basuli, MD PhD retweeted
DARE-ESKD 1: Pharmacokinetic Properties of SGLT2 inhibitor (SGLT2i) Dapagliflozin in Patients on Hemodialysis and Peritoneal Dialysis ca. 2023 from @CJASN #Nephpearls - Well tolerated - Slightly dialyzable - Non-accumulating pharmacokinetic properties pubmed.ncbi.nlm.nih.gov/3722… – at Riverside, IL
2
141
5
329
41,301
Debargha Basuli, MD PhD retweeted
Looks like you can #Flozinate your dialysis patients! "In individuals with kidney failure on dialysis, dapagliflozin was well-tolerated, slightly dialyzable, and had non-accumulating pharmacokinetic properties" journals.lww.com/cjasn/_layo…
9
90
4
252
65,309
Debargha Basuli, MD PhD retweeted
✅IT OUT 👇 📢📢📢Tweetorial Alert (1/19)! What is the most common complication of routine outpatient hemodialysis (HD) treatments?
15%Infection
2%Thrombosis
64%Hypotension
19%Anemia
527 votes • Final results
2
32
3
40
12,299
Debargha Basuli, MD PhD retweeted
Genomics in Glomerular Disease A GlomCon Pubs summary on genetic diagnoses of glomerular diseases by Dr. Benjamin Tan @NephBen Read more 👉🏻 pubs.glomcon.org/genomics-in… #GlomCon
1
12
1
20
7,557
Debargha Basuli, MD PhD retweeted
Our article in @NatRevImmunol proposes that nephritis can be classified primarily according to cause, then by the lesion. This would improve management, education, understanding and research. Thanks to @hjanders_hans @PRomagnani and Prof Nelson Leung for a great collaboration.
Glomerulonephritis: immunopathogenesis and immunotherapy dlvr.it/Sgmj79
2
21
57
6,827
Debargha Basuli, MD PhD retweeted
Ambulatory Hemodialysis Unit Rounds: Called to see a patient with hypotension: BP 76/40,🧠 OK, CRT 5 seconds 1st step ➡️🛑Ultrafiltration + 300 ml bolus. BP 90/60 Pt is a middle aged ♂️ w ESRD and T2DM 1/9 🧵
18
153
15
537
181,863
Debargha Basuli, MD PhD retweeted
📌 A very comprehensive stepwise ECG algorithm 👉 to predict site of origin of idiopathic VAs #ECG #CardioTwitter #EPeeps @adribaran @ECGTalk @DrFerminGarcia @DrJasonAndrade @DhirajGuptaBHRS @SeguraCardio @jvillacastin @smithECGBlog @AskDrShashank @ecgrhythms @iamritu @Hragy
14
270
6
756
102,032
Debargha Basuli, MD PhD retweeted
#AKIConsultSeries:👨w T2DM➡️🏥 for fever, dysuria and CVA tenderness. On arrival: ⬇️BP, ⬆️Glucose, ⬆️AGMA. Dx UTI + DKA. Tx: Abx + Insulin Pump + 4 L Crystalloid + NE After resus, pt still oliguric, Cr 3.2. NE 0.7 ug/kg/min,🧠confused, BP 85/62, HR 123, 2L O2. CRT 4 sec 1/12
27
188
14
570
Debargha Basuli, MD PhD retweeted
1) Welcome to this new #accredited #tweetorial on best practices for providing #interprofessional, multidisciplinary, and multimodal pharmacologic therapy for patients with #CKD-associated anemia #aCKD. #MedTwitter #FOAMed #nephtwitter @MedTweetorials
1
19
1
28
Debargha Basuli, MD PhD retweeted
sacubitril...any data in ESRD? #AskRenal
9
11
1
40
Debargha Basuli, MD PhD retweeted
1) Welcome to a new #accredited #tweetorial on the latest advances in the management of #CKD in the setting of patients with and without #T2D--this time with a hot-off-the-presses update from #ASN22 #KIDNEYWEEK2022: eagerly-awaited results of the #EMPA_KIDNEY trial.
2
21
56
Debargha Basuli, MD PhD retweeted
KDIGO is pleased to announce the publication of the 2022 Diabetes Management in CKD Guideline. Read the Guideline: kdigo.co/2022-Diabetes-in-CK… Read the Executive Summary: kdigo.co/2022-Diabetes-Guide… Read the News Release: kdigo.co/News-Release-2022-D… #diabetes #CKD
6
326
13
624
Debargha Basuli, MD PhD retweeted
🧵Complex #Hemodynamics in ESRD: Middle age pt ➡️ 🏥 for syncope HPI: Low BP during HD sessions. Does not achieve dry weight. Today she has had 6 episodes of syncope! Last episode happened as she stood up from a chair BP 88/62, HR 87 🧠 OK, CRT 2 sec 1/8
15
92
18
257